Effect of chloride ion on dissolution of different salt forms of haloperidol, a model basic drug

Journal of Pharmaceutical Sciences
Shoufeng LiAbu T M Serajuddin


The effect of chloride ion (Cl-) on dissolution rates of hydrochloride, mesylate (methanesulfonate) and phosphate salt forms of a model drug, haloperidol, was investigated. The dissolution rates of the salts in 0.01 M HCl from rotating disks followed the order of mesylate>phosphate>hydrochloride. With additional chloride ion, a decrease in dissolution rate of the hydrochloride salt was observed due to the common ion effect. Dissolution rates of mesylate and phosphate salts also decreased due to their conversion to the HCl salt form on the surfaces of dissolving disks, however, the dissolution rates of mesylate and phosphate salts under identical chloride ion concentrations were still higher than that of the HCl salt. In powder dissolution studies, it was observed that kinetics of nonhydrochloride-to-hydrochloride salt conversion play a major role in dissolution; the mesylate dissolved completely (<5 min) before its dissolution rate could be impeded by its conversion to the hydrochloride salt form. Therefore, despite the potential for conversion to a hydrochloride salt form, certain nonhydrochloride salt forms may still be preferred for dosage form development due to kinetic advantages during dissolution, such as higher apparent...Continue Reading


Jan 1, 1981·Journal of Pharmaceutical Sciences·K G MooneyV J Stella
Mar 22, 2001·Advanced Drug Delivery Reviews·D Hörter, J B Dressman

❮ Previous
Next ❯


Apr 12, 2008·Pharmaceutical Research·Ekarat JantratidJennifer B Dressman
Nov 5, 2008·Chemical & Pharmaceutical Bulletin·Takayuki YoshidaTakahiro Uchida
Apr 1, 2009·Expert Opinion on Drug Metabolism & Toxicology·Kiyohiko Sugano
Oct 25, 2014·Drug Development and Industrial Pharmacy·Shashank JainSenshang Lin
Jan 4, 2012·Journal of Pharmaceutical Sciences·Kristyn Greco, Robin Bogner
Aug 1, 2009·Journal of Pharmaceutical Sciences·Hagar I LaboutaGhaly M Ghaly
Feb 20, 2014·Journal of Pharmaceutical Sciences·Divyakant DesaiPeter Timmins
May 28, 2005·Journal of Pharmaceutical Sciences·Shoufeng LiAbu T M Serajuddin
Jan 30, 2010·Journal of Pharmaceutical Sciences·David P ElderFrank David
Nov 28, 2012·International Journal of Pharmaceutics·David P ElderHeidi Lopez de Diego
Sep 25, 2012·International Journal of Pharmaceutics·Jan P Möschwitzer
Aug 23, 2011·International Journal of Pharmaceutics·V VemulapalliA K Banga
Jul 10, 2007·Advanced Drug Delivery Reviews·Abu T M Serajuddin
Oct 24, 2006·Drug Discovery Today·Shobha N BhattacharJames A Wesley
Aug 18, 2016·Drug Development and Industrial Pharmacy·Xiaoting LiTianhong Zhang
Nov 26, 2009·Chemistry & Biodiversity·Alex AvdeefDmytro Voloboy
Feb 7, 2013·Pharmacological Reviews·Hywel D WilliamsChristopher J H Porter
Mar 10, 2017·Drug Development and Industrial Pharmacy·Haichen NieQi Tony Zhou
Jan 24, 2021·International Journal of Pharmaceutics·Peter J Skrdla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here